Evidence map›Paper›PMID 31147539›Full record

ArticleNature communications2019

The metabolites NADP

Michael A Estrella, Jin Du, Li Chen, Sneha Rath, Eliza Prangley, Alisha Chitrakar, Tsutomu Aoki, Paul Schedl, Joshua Rabinowitz, Alexei Korennykh

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Zoological research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Identification of CCR4C as a chloroplast-localized NADP(H) phosphatase regulating NAD(P)(H) balance inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Regulation of and challenges in targeting NADNature reviews. Molecular cell biology · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Structural basis for Tpt1-catalyzed 2'-POProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Michael A Estrella216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ, 08544, USA.ORCID http://orcid.org/0000-0002-1721-9418
Jin Du216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ, 08544, USA.ORCID http://orcid.org/0000-0002-8224-250X
Li Chen285 Frick Laboratory, Department of Chemistry, Princeton, NJ, 08544, USA.
Sneha Rath216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ, 08544, USA.
Eliza Prangley216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ, 08544, USA.
Alisha Chitrakar216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ, 08544, USA.
Tsutomu Aoki216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ, 08544, USA.
Paul Schedl216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ, 08544, USA.
Joshua Rabinowitz285 Frick Laboratory, Department of Chemistry, Princeton, NJ, 08544, USA. joshr@princeton.edu.
Alexei Korennykh216 Schultz Laboratory, Department of Molecular Biology, Princeton, NJ, 08544, USA. akorenny@princeton.edu.
Princeton University · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
Tumor cell metabolism in actionR01CA163591 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI JOSHUA D RABINOWITZ, Eileen P. White · 2012 to 2026
$7.0M
Metabolism in Action: Quantitative Fluxes in MammalsDP1DK113643 · NIDDK · PRINCETON UNIVERSITY · PI RABINOWITZ, JOSHUA D · 2016 to 2020
$5.7M
Genetic regulatory mechanism in development and differentiationR35GM126975 · NIGMS · PRINCETON UNIVERSITY · PI SCHEDL, PAUL D · 2018 to 2022
$3.0M
Structure and Function of Kinase Family Receptors Regulating TranslationR01GM110161 · NIGMS · PRINCETON UNIVERSITY · PI KORENNYKH, ALEXEI · 2014 to 2022
$2.5M
Beyond infection: Innate immune receptors as an emerging brake on metastasisF99CA212468 · NCI · PRINCETON UNIVERSITY · PI RATH, SNEHA PRAKASH · 2016 to 2017
$89k
Lustgarten Foundation (Lustgarten Foundation for Pancreatic Cancer Research) SU2C-AACR-DT-20-16NCI NIH HHS F99 CA212468NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA163591NIDDK NIH HHS DP1 DK113643NIGMS NIH HHS P41 GM111244NIGMS NIH HHS R01 GM110161NIGMS NIH HHS R35 GM126975U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) 1R01GM110161
6 · The paper itself

Abstract

Nocturnin (NOCT) is a rhythmically expressed protein that regulates metabolism under the control of circadian clock. It has been proposed that NOCT deadenylates and regulates metabolic enzyme mRNAs. However, in contrast to other deadenylases, purified NOCT lacks the deadenylase activity. To identify the substrate of NOCT, we conducted a mass spectrometry screen and report that NOCT specifically and directly converts the dinucleotide NADP

Identifiers

PMID31147539
PMCPMC6542800
OpenAlexW2952861357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.